Company Filing History:
1 out of 47 
1 out of 321 
Years Active: 2014
Title: Hwa-Young Son: Innovator in Pharmaceutical Composition for Inflammatory Diseases
Introduction
Hwa-Young Son is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of inflammatory diseases and asthma. With a total of 2 patents, his work focuses on innovative compositions that utilize natural extracts to combat these health issues.
Latest Patents
Hwa-Young Son's latest patents include a pharmaceutical composition aimed at preventing and treating inflammatory diseases or asthma. This composition comprises an extract that has shown efficacy in inhibiting the increase of eosinophils in bronchoalveolar lavage fluid in an ovalbumin-induced asthma animal model. The extract also demonstrated the ability to inhibit the secretions of immunoglobulin and chemokine, as well as suppressing the release of nitric oxide and TNF-α in macrophages. This innovation positions the extract as a valuable active ingredient in pharmaceutical compositions and health functional foods.
Another significant patent involves a pharmaceutical composition for the prophylaxis and therapy of inflammatory and allergic diseases, including asthma. This composition features a velvet apple extract, which has been found to inhibit the nuclear translocation of NF-κB, a key player in inflammatory responses. The velvet apple extract effectively suppresses the production of nitric oxide and PGE, as well as the expression of iNOS and COX-2. Furthermore, it down-regulates Th2-mediated IL-4 and IL-13 production, showcasing its potential in treating various inflammatory disorders.
Career Highlights
Hwa-Young Son has worked with esteemed institutions such as the Korea Institute of Oriental Medicine and the Korea Research Institute of Bioscience and Biotechnology. His research has significantly advanced the understanding and treatment of inflammatory diseases, making him a key figure in the pharmaceutical industry.
Collaborations
Hwa-Young Son has collaborated with notable colleagues, including Sei Ryang Oh and Kyung Seop Ahn, who have contributed to his research endeavors. Their combined expertise has further enhanced the impact of his innovations in the field.
Conclusion
Hwa-Young Son's contributions to pharmaceutical compositions for inflammatory diseases and asthma highlight his role as an innovative inventor. His patents reflect a commitment to developing effective treatments that leverage natural extracts, paving the way for advancements in healthcare.